| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.046 | 0.3 |